Gene Sequencing Market will reach at $ 23.54 billion by 2032-Roche, GE Healthcare Life Sciences, Thermo Fisher Scientific, Johnson & Johnson, Oxford Nanopore, Illumina, Pacific Biosciences, Beckman Coulter, Abbott Laboratories

The global DNA sequencing market size was valued at USD 5.45 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.4% from 2020 to 2032. Gene Sequencing market will reach at $ 23.54 billion by 2032, Rapid advancements in sequencing technology and bioinformatics have enabled the identification of DNA variations. These advancements also determine variants associated with increased risk for disease. With a widespread application of Next-generation Sequencing (NGS) and Whole-genome Sequencing (WGS), a large range of genes can be tested in a single diagnostic platform at the same time, which expands the utility of DNA sequencing in clinical diagnosis applications. Personalized targeted sequencing of tumor accelerates the identification of mutations and further identifies cancer target or pathway for which pharmacological treatments are developed. The emergence of global-scale projects incorporating NGS protocols generates new foundational knowledge about oncology precision medicine.

Get an Exclusive Sample of Report on the Gene Sequencing market is available : https://www.mraccuracyreports.com/report-sample/352394

Product Insights
Consumables dominated the DNA sequencing market with a revenue share of 43.3% in 2019. The wide availability of reagents and kits to cater to all steps of library construction, such as DNA fragmentation, enrichment, adapter ligation, amplification, and quality control contributes to a larger share of the segment. Most of these tools feature streamlined and simplified workflows, ready-to-use components, and compatibility with low-input and formalin-fixed specimens.

The constant introduction of reagents and kits to make WGS more accessible and affordable also drives the segment in the market for DNA sequencing. For instance, in August 2020, Illumina Inc. launched NovaSeq 6000 v1.5 Reagent Kit, which made the WGS technique more cost-effective and accessible for all the laboratories and reduced the cost to sequence a human genome for USD 600. These new kits can be used across WGS, single-cell genomics, and liquid biopsy techniques.
Top Companies in this report are: Roche, GE Healthcare Life Sciences, Thermo Fisher Scientific, Johnson & Johnson, Oxford Nanopore, Illumina, Pacific Biosciences, Beckman Coulter, Abbott Laboratories

Gene Sequencing Market Overview:

Gene Sequencing Market research is an intelligence report with meticulous efforts to study the right and valuable information. The data considers both the existing top players and the upcoming internet competitors. Global Forecast to 2027 latest report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the Gene Sequencing market.This market research report is a compilation of informative data that gives an all-inclusive analysis of the current trend for the forecast period. Our report offers a comprehensive account of the current state of the market and describes its future prospects as well. We also illustrate how to make future business plans based on our predictions.

Workflow Insights
Sequencing is the major step of the entire workflow and held the maximum revenue share of 52.8% in 2019 in the market for DNA sequencing. This step enables the sequence profiling of the genome as well as DNA-protein interactions. It is an integral part of the entire DNA sequencing workflow in research and discovery studies, thereby accounting for a larger share. The ability of sequencers to generate a large amount of data in a relatively short period accelerates understanding of human health and disease treatments.

Besides, the advent of Paired-End (PE) sequencing results in the advancement in this workflow, further contributing to segment growth in the market for DNA sequencing. PE sequencing allows the DNA fragments to sequence from both ends, which produces twice the number of reads in a similar time. Sequences aligned as read-pairs allow accurate read alignment and detection of indels that are not possible with single-read data.

Gene Sequencing Market Segmentation by Type:

Emulsion PCR, Bridge Amplification, Single-molecule.

Gene Sequencing Market Segmentation by Application:

Molecular Biology, Evolutionary Biology, Metagenomics, Medicine, Other

Application Insights
In terms of revenue, oncology dominated the market for DNA sequencing and accounted for the maximum revenue share of 24.4% in 2019. The technology holds great potential in clinical research and development of cancer diagnostics and therapeutics. Recently, NGS technology has demonstrated the capacity as a high-throughput and an affordable approach in the identification and characterization of clinically actionable genetic variants across numerous genes at an exceptional speed in a single test.

Access full Report Description, TOC, Table of figures, Chart, etc.: https://www.mraccuracyreports.com/reportdetails/reportview/352394

Regional Insights
North America dominated the market for DNA sequencing and accounted for the largest revenue share of 44.3% in 2019. Continuous technological developments by key players, high investment in R&D, and availability of technologically advanced healthcare infrastructure have resulted in North America's leading share in the market for DNA sequencing. The presence of several government initiatives in the U.S. and Canada supports research in drug development and treatment of cancer.

For instance, the Personalized Onco-Genomics program of the BC Cancer Foundation, a part of the Provincial Health Services Authority in British Columbia, Canada, utilizes transcriptome and whole-genome analysis to determine cancer genes and identifies corresponding drugs. These drugs can inhibit the relevant pathways in cancer-affected patients. Such public programs are expected to boost the application of these technologies in the region.

Gene Sequencing Market Share Analysis: Knowing Gene Sequencing's market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the Gene Sequencing market characteristics in accumulation, dominance, fragmentation, and amalgamation traits.

The report answers questions such as:

What is the Gene Sequencing market size and forecast of the Global Market?
What are the inhibiting factors and impact of COVID-19 shaping the Global Gene Sequencing Market during the forecast period?
Which products/segments/applications/areas to invest in over the forecast period in the Global Gene Sequencing Market?
What modes and strategic moves are suitable for entering the Global Gene Sequencing Market?
Direct Purchase this Market Research Report Now @ https://www.mraccuracyreports.com/checkout/352394

If you have any special requirements, please let us know and we will offer you the report as you want.

Call Us - UK +44 7452119323
USA +1 8045001224
Email us - sales@mraccuracyreports.com
30 Crawley Lane, West Sussex, RH10 7EG, United Kingdom
3351 Green Turtle Rd, Regina, SK S4V 3N6, Canada

MR Accuracy Reports is a Market Research and consulting company that accomplishes requirement of research agencies,small, medium and large corporations, global business leaders, government organizations,
SME's, Individual & Start-ups, top management consulting firms

This release was published on openPR.